Portal de Periódicos da CAPES

Twelve-month results from a randomized controlled trial comparing differential target multiplexed spinal cord stimulation and conventional spinal cord stimulation in subjects with chronic refractory axial low back pain not eligible for spine surgery

2024; Elsevier BV; Volume: 19; Linguagem: Inglês

10.1016/j.xnsj.2024.100528

2666-5484

Thomas White, Rafael Justiz, Wilson Almonte, Velimir Micovic, Binit Shah, Eric Anderson, Leonardo Kapural, Harold Cordner, Amr El‐Naggar, Michael Fishman, Yashar Eshraghi, Philip Kim, Alaa Abd‐Elsayed, Krishnan Chakravarthy, Yoann Millet, Mahendra Sanapati, Nathan J. Harrison, Brandon J. Goff, Mayank Gupta, Prabhdeep Grewal, Michael Wilkinson, Richard Bundschu, Andrew Will, Pankaj Satija, Sean Li, Scott C. Dulebohn, John P. Broadnax, Gennady Gekht, Ken Wu, Steven Falowski, Wesley Park, David L. Cedeño, Ricardo Vallejo,

Myofascial pain diagnosis and treatment

Successful treatments for intractable chronic low back pain (CLBP) in patients who are not eligible for surgical interventions are scarce. The superior efficacy of differential target multiplexed spinal cord stimulation (DTM SCS) to conventional SCS (Conv-SCS) on the treatment of CLBP in patients with persistent spinal pain syndrome (PSPS) who have failed surgical interventions (PSPS-T2) motivated the evaluation of DTM SCS versus Conv-SCS on PSPS patients who are non-surgical candidates (PSPS-T1).